A physiologically based mathematical model of integrated calcium homeostasis and bone remodeling

Peterson, Mark C., Riggs, Matthew M.·2010·Bone
DOI 10.1016/j.bone.2009.08.053

Cited by (198)

Items 101–198 of 198

  1. Benefits and challenges of a QSP approach through case study: Evaluation of a hypothetical GLP-1/GIP dual agonist therapy
    Theodore R. Rieger, Cynthia J. Musante · 2016 · European Journal of Pharmaceutical Sciences
  2. Quantitative Systems Pharmacology: Applications and Adoption in Drug Development
    Saroja Ramanujan, Kapil G. Gadkar, Ananth Kadambi · 2016 · AAPS advances in the pharmaceutical sciences series
  3. Transient modulation of calcium and parathyroid hormone stimulates bone formation
    Andy B. Chen, Kazumasa Minami, João Filipe Raposo, Nariaki Matsuura∥, Masahiko Koizumi, Hiroki Yokota, Hugo Gil Ferreira · 2016 · Endocrine
  4. Population Pharmacokinetic and Pharmacodynamic Modeling of Etelcalcetide in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism Receiving Hemodialysis
    Ping Chen, Adimoolam Narayanan, Benjamin M. Wu, Per Olsson Gisleskog, John P. Gibbs, Andrew T. Chow, Murad R. Melhem · 2017 · Clinical Pharmacokinetics
  5. Quantitative prediction of bone mineral density by using bone turnover markers in response to antiresorptive agents in postmenopausal osteoporosis: A model‐based meta‐analysis
    Junyi Wu, Chen Wang, Guo‐Fu Li, En‐Tzu Tang, Qingshan Zheng · 2020 · British Journal of Clinical Pharmacology
  6. Application of a Systems Pharmacology‐Based Placebo Population Model to Analyze Long‐Term Data of Postmenopausal Osteoporosis
    J Berkhout, JA Stone, Katia M.C. Verhamme, Bruno H. Ch. Stricker, Miriam Sturkenboom, Meindert Danhof, TM Post · 2015 · CPT Pharmacometrics & Systems Pharmacology
  7. Mathematical modeling of calcium homeostasis in female rats: An analysis of sex differences and maternal adaptations
    Stadt, Melissa M., Layton, Anita T. · 2023 · Journal of Theoretical Biology
  8. Use of Artificial Intelligence to Identify New Mechanisms and Approaches to Therapy of Bone Disorders Associated With Chronic Kidney Disease
    Adam E. Gawęda, Eleanor DeLand Lederer, Michael E. Brier · 2022 · Frontiers in Medicine
  9. Pharmacometrics: The Already-Present Future of Precision Pharmacology
    Lorena Cera Bandeira, Leonardo Pinto, Cláudia Martins Carneiro · 2022 · Therapeutic Innovation & Regulatory Science
  10. Cross-Domain Text Mining of Pathophysiological Processes Associated with Diabetic Kidney Disease
    Krutika Patidar, Jennifer Deng, Cassie S. Mitchell, Ashlee N. Ford Versypt · 2024 · International Journal of Molecular Sciences
  11. Modeling effects of dexamethasone on disease progression of bone mineral density in collagen‐induced arthritic rats
    Hoi‐Kei Lon, Debra C. DuBois, Justin C. Earp, Richard R. Almon, William J. Jusko · 2015 · Pharmacology Research & Perspectives
  12. The Lattice Boltzmann method and computational analysis of bone dynamics-I
    Sana Javed, Ayesha Sohail, Khadija Maqbool, Saad Ihsan Butt, Qasim Ali Chaudhry · 2017 · Complex Adaptive Systems Modeling
  13. Intra-skeletal vascular density in a bipedal hopping macropod with implications for analyses of rib histology
    Tahlia J. Stewart, Julien Louys, Justyna Jolanta Miszkiewicz · 2021 · Anatomical Science International
  14. Solving the Evidence Interpretability Crisis in Health Technology Assessment: A Role for Mechanistic Models?
    Eulalie Courcelles, Jean‐Pierre Boissel, Jacques Massol, Ingrid Klingmann, Riad Kahoul, Marc Hommel, Emmanuel Pham, Alexander Jan Kulesza · 2022 · Frontiers in Medical Technology
  15. The Experimental Side of Parameter Estimation
    Monica Schliemann-Bullinger, Dirk Fey, Thierry Bastogne, Rolf Findeisen, Peter Scheurich, Eric Bullinger · 2015 · Studies in mechanobiology, tissue engineering and biomaterials
  16. Application of artificial intelligence to chronic kidney disease mineral bone disorder
    Eleanor DeLand Lederer, Mahmoud Sobh, Michael E. Brier, Adam E. Gawęda · 2024 · Clinical Kidney Journal
  17. Machine learning progressive CKD risk prediction model is associated with CKD-mineral bone disorder
    Joseph Aoki, Omar M. Khalid, Cihan Kaya, Tarush Kothari, Mark A. Silberman, Con Skordis, Jonathan A. Hughes, Jerry W. Hussong, Mohamed E. Salama · 2024 · Bone Reports
  18. A novel approach in analyzing agriculture and food systems: Review of modeling and its applications
    Do‐Gyun Kim, Byoung–Kwan Cho, Wang‐Hee Lee · 2016 · Korean Journal of Agricultural Science
  19. A Multi-Compartment Model Capturing the Pharmacokinetics of the Calcimimetic Cinacalce
    Gudrun Schappacher‐Tilp, Doris Helene Fuertinger, Peter Kotanko · 2019 · Cellular Physiology and Biochemistry
  20. Mathematical models for phosphate kinetics in patients on maintenance hemodialysis
    Jacek Waniewski, Małgorzata Dębowska, Alicja Wójcik-Załuska, Wojciech Załuska, Bengt Lindholm · 2025 · Scientific Reports
  21. Bridging adults and paediatrics with secondary hyperparathyroidism receiving haemodialysis: a pharmacokinetic‐pharmacodynamic analysis of cinacalcet
    Ping Chen, Winnie Y. Sohn, Adimoolam Narayanan, Per Olsson Gisleskog, Murad R. Melhem · 2019 · British Journal of Clinical Pharmacology
  22. Communicating to Influence Drug Development and Regulatory Decisions: A Tutorial
    S Mehrotra, Jogarao V. S. Gobburu · 2016 · CPT Pharmacometrics & Systems Pharmacology
  23. Dynamics of bone cell signaling and PTH treatments of osteoporosis
    DAVID S. ROSS, Christina Battista, Antonio Cabal, Khamir Mehta · 2012 · Discrete and Continuous Dynamical Systems - B
  24. Establishment of a Disease‐Drug Trial Model for Postmenopausal Osteoporosis: A Zoledronic Acid Case Study
    Yi Ting Lien, Kumpal Jagdish Madrasi, Snehal Samant, Myong‐Jin Kim, Fang Li, Li Li, Yaning Wang, Stephan Schmidt · 2020 · The Journal of Clinical Pharmacology
  25. Application of Disease System Analysis to Osteoporosis: From Temporal to Spatio-Temporal Assessment of Disease Progression and Intervention
    Silvia Trichilo, Peter Pivonka · 2017 · Courses and lectures
  26. Application of Quantitative Systems Pharmacology Approaches to Support Pediatric Labeling in Rare Diseases
    Susana Zaph, Randolph J. Leiser, Mengdi Tao, Chanchala D. Kaddi, Christine R. Xu · 2024 · Handbook of experimental pharmacology
  27. A Pharmacometric Workflow for Resolving Model Instability in Model Use‐Reuse Settings
    Stephen Brent Duffull, Daniel F. B. Wright, Xiao Zhu, Xin Liu, Ahmed Aliyu Abulfathi, Hailemichael Zeru Hishe · 2025 · CPT Pharmacometrics & Systems Pharmacology
  28. Population Pharmacokinetic and Exposure–Response Analysis of Weekly Teriparatide in Osteoporosis Patients
    Atsushi Ose, Masashi Serada, Keiko Yamashita, Kazuyuki Tsurui, Yusuke Tanigawara · 2017 · The Journal of Clinical Pharmacology
  29. Systems Pharmacology and Pharmacodynamics: An Introduction
    Donald E. Mager, Holly H. C. Kimko · 2016 · AAPS advances in the pharmaceutical sciences series
  30. Systems Modeling of Bortezomib and Dexamethasone Combinatorial Effects on Bone Homeostasis in Multiple Myeloma Patients
    Li Zhang, Donald E. Mager · 2018 · Journal of Pharmaceutical Sciences
  31. Validation of a quantitative systems pharmacology model of calcium homeostasis using elagolix Phase 3 clinical trial data in women with endometriosis
    Sven Stodtmann, Ahmed M. Nader, Akshanth R. Polepally, Ahmed A. Suleiman, Insa Winzenborg, Peter A. Noertersheuser, Juki Ng, Nael Mohamed Mostafa, Mohamad Shebley · 2021 · Clinical and Translational Science
  32. The Grand Challenge for Integrative and Regenerative Pharmacology
    George Joseph Christ, Alex F. Chen · 2011 · Frontiers in Pharmacology
  33. Advances in computational modeling of cytokine and growth factor dynamics in bone healing: a scoping review
    Ahmad Hedayatzadeh Razavi, Nazanin Nafisi, Maria Virginia Velasquez Hammerle, Mohammad Javad Shariyate, Mohammad Khak, Alireza Mirahmadi, Megan C. McNichol, Edward K. Rodrogiuez, Ara Nazarian · 2025 · Biomechanics and Modeling in Mechanobiology
  34. Effect of Rotation on Wave Propagation in Hollow Poroelastic Circular Cylinder
    Sayed Mohamed Abo-Dahab, A. M. Abd-Alla, S. Alqosami · 2014 · Mathematical Problems in Engineering
  35. Nonlinear modeling and control strategies for bone diseases based on TGF β and Wnt factors
    José Ariel Camacho-Gutíerrez, Silvia Jerez · 2021 · Communications in Nonlinear Science and Numerical Simulation
  36. A multi‐model approach to predict efficacious clinical dose for an anti‐TGF ‐β antibody ( GC2008 ) in the treatment of osteogenesis imperfecta
    Panteleimon D. Mavroudis, Nikhil Pillai, Qingping Wang, Clemence Pouzin, Benjamin Greene, Jennifer Fretland · 2022 · CPT Pharmacometrics & Systems Pharmacology
  37. Clinical and translational pharmacology of bisphosphonates
    Serge Cremers, Matthew T. Drake, Frank H. Ebetino, Michael J. Rogers, John Paul Bilezikian, R.G.G. Russell · 2019 · Elsevier eBooks
  38. An Evaluation of Calcilytic Effects on Parathyroid Hormone and Bone Mineral Density Response Using a Physiologically-Based, Multiscale Systems Pharmacology Model
    Kyle T. Baron, Matthew M. Riggs, Ryoko Sawamura, Takako Shimizu, Fumihiko Okada, Jin Zhou, Takahiro Shibayama, Mendel Jansen · 2013
  39. MODEL-BASED ANALYSIS OF IGF-1 EFFECT ON OSTEOBLAST AND OSTEOCLAST REGULATION IN BONE TURNOVER
    Wang‐Hee Lee, Martin R. Okos · 2016 · Journal of Biological Systems
  40. Computational simulations of endocrine bone diseases related to pathological glandular PTH secretion using a multi-scale bone cell population model
    Corinna Modiz, Natalia Mühl Castoldi, Stefan Scheiner, Javier Martínez‐Reina, José Luis Calvo‐Gallego, Vittorio Sansalone, Saulo Martelli, Peter Pivonka · 2025 · Frontiers in Bioengineering and Biotechnology
  41. Quantitative systems pharmacology models: unleashing their potential in cancer immunotherapy
    Junsheng Xue, Yonghyun Lee, Tianyan Zhou · 2025 · Journal of Pharmaceutical Investigation
  42. EXPLORING THE IMPACT OF PTH THERAPY ON BONE REMODELING: A MATHEMATICAL INVESTIGATION
    Amrutha Sreekumar, KOYEL CHAKRAVARTY · 2024 · Journal of Biological Systems
  43. Leveraging quantitative systems pharmacology and artificial intelligence to advance treatment of chronic kidney disease mineral bone disorder
    Adam E. Gawęda, Michael E. Brier, Eleanor DeLand Lederer · 2024 · American Journal of Physiology-Renal Physiology
  44. The Use of Population Pharmacokinetic and Pharmacodynamic Modeling and Simulation in Anti-Osteoporotic Drug Development: A Perspective
    Chihiro Hasegawa, Tomoya OHNO, Ichiro Ieiri · 2014 · Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics
  45. An introduction to QSP modeling for pharmacologists
    Hiroyuki Sayama, Yasuhisa Nagasaka, Kenji Tabata · 2019 · Folia Pharmacologica Japonica
  46. Disease progress models
    Diane R. Mould, Nicholas H. G. Holford, Carl C. Peck · 2021 · Elsevier eBooks
  47. Review on Application of Biosystem Modeling: Introducing 3 Model-based Approaches in Studying Ca Metabolism
    Wang‐Hee Lee, Byoung–Kwan Cho · 2012 · Journal of Biosystems Engineering
  48. Nonlinear Mixed Effects Modeling in Systems Pharmacology
    Peter L. Bonate, Amit V. Desai, Ahsan Rizwan, Lu Zheng, Stacey J. Tannenbaum · 2016 · AAPS advances in the pharmaceutical sciences series
  49. Industrialization of Quantitative Systems Pharmacology
    Brian Gregory Topp, Maria E. Trujillo, Vikram P. Sinha · 2019 · CPT Pharmacometrics & Systems Pharmacology
  50. Physics‐Based Modeling for the Physiome
    William Andrew Pruett, Robert L. Hester · 2016
  51. In silico model of mechano-biochemical bone remodeling characterizes the therapeutic effects of osteoporosis drugs depending on the action mechanism
    Yoshitaka KAMEO, Kei Imai, Yuki MIYA, Young Kwan Kim, Taiji ADACHI · 2025 · Biomedical Engineering Advances
  52. Parathyroid hormone secretion by multiple distinct cell populations, a time dynamic mathematical model
    William Andrew Pruett, Robert L. Hester · 2014 · Physiological Reports
  53. When Learn/Confirm Leads to Expand/Understand: The Expanding Role of Quantitative Systems Pharmacology in the Betterment of Therapeutics Development
    Matthew M. Riggs · 2018 · Clinical Pharmacology & Therapeutics
  54. Use of statistical and pharmacokinetic–pharmacodynamic modeling and simulation to improve decision-making: A section summary report of the trends and innovations in clinical trial statistics conference
    Holly H. C. Kimko, Seth Berry, Michael O’Kelly, Nitin Mehrotra, Matthew M. Hutmacher, Venkat S. Sethuraman · 2017 · Journal of Biopharmaceutical Statistics
  55. Joint inference of physiological network and survival analysis identifies factors associated with aging rate
    Anurag Sethi, Eugene Melamud · 2022 · Cell Reports Methods
  56. Reusing Smaller Versions of Large Models: A Case Example of Reuse of a Simplified Bone Model
    Chihiro Hasegawa, Stephen Brent Duffull · 2019 · Clinical Pharmacology & Therapeutics
  57. The Role of Cross-Institutional and Interdisciplinary Collaboration in Defining and Executing a Quantitative Systems Pharmacology Strategy
    Paolo Vicini, Piet H. van der Graaf · 2024 · Handbook of experimental pharmacology
  58. Modeling calcium and magnesium balance: effects of diuretics
    Pritha Dutta, Anita T. Layton · 2025 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
  59. A mathematical model of bone formation and resorption: effect of calcitonin
    Chontita Rattanakul, Sahattaya Rattanamongkonkul · 2011 · International Conference on Applied Mathematics
  60. Integrated mathematical models for describing complex biological processes
    E. L. Mishchenko, O. V. Petrovskaya, A. M. Mishchenko, E. D. Petrovskiy, Nikita V. Ivanisenko, В. А. Иванисенко · 2017 · BIOPHYSICS
  61. A mechanobiological bone remodelling model coupling bone physiology and systemic calcium and phosphorus homeostasis
    Javier Martínez‐Reina, J. Calvo-Gallego, Fernando Gutiérrez-Millán, Peter Pivonka, G. Gresser · 2023 · International Conference on Computational Methods for Coupled Problems in Science and Engineering (COUPLED PROBLEMS)
  62. Personalized parathyroid hormone therapy for hypoparathyroidism: Insights from pharmacokinetic‐pharmacodynamic modelling
    Maira Visscher, Manon Schuls‐Fouchier, Annika M. A. Berends, Anneke C. Muller Kobold, Nieko C. Punt, Daan Johannes Touw · 2024 · British Journal of Clinical Pharmacology
  63. Pharmacologic mechanisms of therapeutics
    Donovan Tay, Gaia Tabacco, Serge Cremers, John Paul Bilezikian · 2019 · Elsevier eBooks
  64. Development of a Computational Modelling Platform for Patient-specific Treatment of Osteoporosis
    Madge Martin, Vittorio Sansalone, Peter Pivonka · 2020 · Springer eBooks
  65. Parathyroid Hormone and Cell Signaling in Bone Remodeling
    Christina Battista · 2011 · RIT Scholar Works (Rochester Institute of Technology)
  66. A physiology-based mathematical model of the renin-angiotensin system, bone remodeling, and calcium homeostasis: Effects of estrogen and renin-angiotensin system inhibitors
    Stadt, Melissa M., Layton, Anita T. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  67. Una formulación preliminar de tipo electromecánica para la formación de hueso en un proceso de remodelación
    Angélica Martínez, Diego Alexander Garzón–Alvarado · 2012 · Revista cubana de investigaciones biomédicas
  68. Review of Ca Metabolic Studies and a Model for Optimizing Gastrointestinal Ca Absorption and Peak Bone Mass in Adolescents
    Jong‐Tae Park, Byoung–Kwan Cho, Wang‐Hee Lee · 2015 · Journal of Biosystems Engineering
  69. A control engineering model of calcium regulation
    Christopher R. Christie, Luke E. K. Achenie, Babatunde A. Ogunnaike · 2014 · IFAC Proceedings Volumes
  70. State-of-the-Art Pharmacometric Models in Osteoporosis
    Anna Georgieva Kondic, Antonio Cabal, Ghassan N. Fayad, Khamir Mehta, Thomas Kerbusch, Teun M. Post · 2014 · AAPS advances in the pharmaceutical sciences series
  71. Systems Pharmacology Model Development to Provide Physiologically-Based Interpretation and Drug Development Decision Support in Osteoporosis and Other Bone-Related Diseases
    Steve Martin, Alanna S. Ocampo-Pelland, Elodie L. Plan, Piet Hein van der Graaf · 2013
  72. A PHYSIOLOGICALLY-BASED, MULTISCALE MODEL USED TO PREDICT PROGRESSIVE BONE MINERAL DENSITY LOSS DUE TO CHRONIC RENAL DISEASE
    Matthew M. Riggs, Marc R. Gastonguay, Mark C. Peterson · 2010
  73. Mathematical modelling of calcium influence on the activity of osteogenic cells
    Aurélie Carlier · 2010
  74. Predicting Nonlinear Changes in BMD Over Time using a Physiologically-Based Mathematical Model
    Mark C. Peterson, Matthew M. Riggs · 2010
  75. Calcium/Phosphate Regulation: A Control Engineering Approach
    Christopher R. Christie · 2014 · VTechWorks (Virginia Tech)
  76. Knowledge Sharing, and Training Are Critical for Future Success Pharmacometrics as a Discipline Is Entering the ''Industrialization'' Phase: Standards, Automation,
    R. Gastonguay, Bernd Meibohm, Hartmut Derendorf, Klaus Romero, Brian Corrigan, Christoffer Wenzel Tornøe, Jogarao V. S. Gobburu, Meindert Danhof, William R. Gillespie · 2010
  77. A Control Engineering Perspective of Calcium Homeostasis
    Christopher R. Christie, Luke E. K. Achenie, Babatunde A. Ogunnaike · 2012 · Computer-aided chemical engineering/Computer aided chemical engineering
  78. An Introduction to Systems Biology and Quantitative Systems Pharmacology
    B.C. Gomes · 2017 · Elsevier eBooks
  79. A new conceptual framework for the therapy by optimized multidimensional pulses of therapeutic activity. The case of multiple myeloma model
    Denis Horváth, B. Brutovský · 2018 · Journal of Theoretical Biology
  80. Using ensemble modeling to determine causes of multifactorial disorders
    Ian Rogers, Ranjan Srivastava · 2018 · Genetic and Evolutionary Computation Conference Companion (GECCO Companion)
  81. Mathematical Modeling and Optimization of Active Calcium Absorption in Human Body
    Wang‐Hee Lee, Do‐Gyun Kim · 2019 · Journal of Biosystems Engineering
  82. DEVELOPMENT OF BAYESIAN AND NON-BAYESIAN MELPHALAN PHARMACOKINETIC MODEL FROM LITERATURE-GENERATED DATA
    Enoch Cobbina · 2019
  83. Bone remodelling and mechanomics: Bridging organ, tissue, and cell scales to understand bone structure and function
    Madge Martin · 2020 · Queensland University of Technology
  84. Current World Literature
    2010 · Current Opinion in Endocrinology Diabetes and Obesity
  85. Mathematical Models of Parathyroid Gland Biology: Complexity and Clinical Use
    Gudrun Schappacher‐Tilp, Peter Kotanko, Markus Pirklbauer · 2022 · Frontiers in Nephrology
  86. MODERN SOCIETY & SCIENCE PROGNOSIS & ACHIEVEMENT
    IRETC, Namig Isazade · 2022 · IRETC eBooks
  87. Mechanostat regulation of cortical bone adaptation due to PTH and mechanical loading: Insights from image analysis and in silico modelling of the mouse tibia
    Corey J. Miller · 2023 · Queensland University of Technology
  88. Modeling the Dynamic Effects of Parathyroid Hormone Therapy on Bone Remodeling
    Amrutha Sreekumar, Koyel Chakravarty · 2024 · Springer proceedings in physics
  89. Understanding the Chemical Dynamics of "Viper": A Study in Calcium Homeostasis, Bone Integrity, and Mathematical Modelling in Gotham's Fictional Context
    Ashutosh Kumar, Prakash Kumar, Santosh Dixit, Niranjan Kumar, Badshah Alam · 2025 · EPJ Web of Conferences
  90. Can physical activity augment drug efficacy in PMO treatments - Insights from in-silico simulations of PTH and denosumab treatments
    Rocío Ruiz-Lozano, José Luis Calvo-Gallego, Peter Pivonka, Javier Martínez‐Reina · 2025 · Journal of Theoretical Biology
  91. Physiologie isotopique du Calcium chez les mammifères
    Théo Tacail · 2017
  92. Stratégies de reproduction mammaliennes et isotopie du calcium : témoins actuels et perspectives fossiles
    Auguste Hassler · 2021
  93. Évaluation de la balance minérale osseuse à l'aide des isotopes stables et naturels du calcium et du magnésium dans les biofluides humains
    Samuel Le Goff · 2021
  94. The interrelationship between calcium-phosphorus homeostasis and bone remodelling. Impact of dietary changes on bone in patients with primary hyperparathyroidism and chronic kidney disease
    Javier Martínez‐Reina, José Luis Calvo‐Gallego, Rocío Ruiz-Lozano, Peter Pivonka, Ralph Müller · 2026 · Frontiers in Bioengineering and Biotechnology
  95. Constrained interactions and sublinear multifractality in multiscale systems
    Anonymous, Damian G. Kelty‐Stephen · 2026 · Physical review. E
  96. Optimizing Bone Remodeling: A Control-Theoretic Approach to Model the Combination Therapy of Parathyroid Hormone and Denosumab
    Amrutha Sreekumar, Koyel Chakravarty · 2026 · Journal of Environmental Accounting and Management
  97. Quantitative Systems Pharmacology (QSP): Bridging Biology and Mechanism with Clinical Drug Development Decisions
    Weirong Wang, Alexander Jan Kulesza, Steve Chang, Yougan Cheng, Jingqi Q.X. Gong, Abhishek Gulati, Emma K. Hansson, Alexander Jan Kulesza, Federico Reali, Conner I. Sandefur et al. · 2026 · The Journal of Clinical Pharmacology
  98. Pharmacometric Applications in Inflammation
    Sujatha S. Menon, Sriram Krishnaswami · 2014 · AAPS advances in the pharmaceutical sciences series